The combination of HBI-8000 and nivolumab induced a response in nearly two-thirds of patients with advanced melanoma and no ...

PD-L1 expression was found to predict better outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 levels ...

Opdivo® (nivolumab) is now funded in New Zealand for eligible patients with metastatic clear cell renal cell carcinoma (RCC) (advanced kidney cancer) after prior anti-angiogenic therapy.

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Adjuvant Opdivo showed a significant improvement in overall survival and disease-free survival for patients with high-risk ...

Combination treatment with entinostat and nivolumab results in durable responses in a small subset of patients with advanced ...